‚¨–â‚¢‡‚킹‚ÍTEL.0982-52-5600
§883-0066 ‹{茧“úŒüŽs‹Tè1’š–Ú15”Ô’n
Šw‰ï–¼ | ”•\“ú | ‰‰‘è–¼ |
“ú–{—ΓàáŠw‰ï | 2018”N 9ŒŽ16“úi“új |
ƒVƒ“ƒ|ƒWƒEƒ€ u—Γàáˆâ“`Žq‰ðÍ‚©‚çŒÂ•ʉ»ˆã—ÂÖv |
“ú–{—Õ°Šá‰ÈŠw‰ï | 2018”N 10ŒŽ12“úi‹àj |
ƒVƒ“ƒ|ƒWƒEƒ€ u‚—îŽÒ‚̗Γàáv |
“ú–{Šá‰ÈŠw‰ï‘‰ï | 2019”N 4ŒŽ18“úi–Øj`21“úi“új ‚Ì‚¢‚¸‚ê‚©‚Ì“ú |
ƒTƒuƒXƒyƒVƒƒƒŠƒeƒBƒTƒ“ƒf[ uf’f‚ÆŽ¡—ẪAƒbƒvƒf[ƒg‘±”—Γàáv |
Šw‰ï–¼ | ”•\“ú | ‰‰‘è–¼ |
“ú–{Šá‰ÈŠw‰ï‘‰ï | 2017”N 4ŒŽ6“ú`9“ú |
—Ž‹ûÇŒóŒQ‘å‹K–̓Rƒz[ƒg‚ɑ΂·‚éƒQƒmƒ€ƒƒCƒhŠÖ˜A‰ðÍ |
APAO iƒAƒWƒA‘¾•½—mŠá‰ÈŠw‰ïj |
2017”N 3ŒŽ1“ú`5“ú |
Ocular and systemic manifestations of exfoliation syndrome |
‹ãBŠá‰ÈŠw‰ï | 2017”N 5ŒŽ21“ú |
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[ u—Ž‹ûÇŒóŒQ‚ƗΓàáv |
WGC i¢ŠE—Γàá‰ï‹cj |
2017”N 6ŒŽ28“ú `7ŒŽ1“ú |
Clinical applicability of genetics in exfoliation syndrome |
“ú–{—ΓàáŠw‰ï | 2017”N 9ŒŽ29“ú `10ŒŽ1“ú |
u—Ž‹ûÇŒóŒQ‚ÉŠÖ˜A‚·‚éLysyl oxidase-like 1 (LOXL1)‚É‚¨‚¯‚érare variant ’Tõv“ú–{—Õ°Šá‰ÈŠw‰ï |
“ú–{—Õ°Šá‰ÈŠw‰ï | 2017”N 10ŒŽ12“ú`15“ú |
RMB_ŒoŠá‰È•׋‰ï |
APAO iƒAƒWƒA‘¾•½—mŠá‰ÈŠw‰ïj |
2018”N 2ŒŽ9“ú`11“ú |
Clinical Applicability of Genetics in Exfoliation Syndrome |
APGC iƒAƒWƒA‘¾•½—m—Γàá‰ï‹cj |
2018 ”N4ŒŽ12“ú |
Cautions and Complications in cataract extraction in eyes with exfoliation syndrome |
ARVO iŽ‹Šo‚ÆŠá‰ÈŠwŒ¤‹†‹¦‰ï‰ï‹cj |
2018”N 4ŒŽ28“ú `5ŒŽ5“ú |
Poster: Genetic analysis reveal significant and consistent pairwise interactions
between common non-coding LOXL1 polymorphisms. |
§883-0066
‹{茧“úŒüŽs‹Tè1’š–Ú15”Ô’n
TEL 0982-52-5600